Start free

Exozymes Inc. (EXOZ) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 26, 2026.

Filings shown
11
Open-market buys
5
Open-market sells
1
Buys, 10b5-1 box not checked
5 of 5

Counts cover the 11 most recent Form 4 filings Tradune holds for EXOZ (filed Aug 25 – Oct 26, 2026). SEC EDGAR Form 4 filings for EXOZ last checked Nov 22, 2026, 09:00 UTC; the latest EXOZ filing Tradune holds was filed Oct 26, 2026. This is not guaranteed to be the complete record — see EXOZ's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for EXOZ filed Aug 25 – Oct 26, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

1 open-market sale by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
1 sale· 3,729 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Michael HeltzenChief Executive Officer 5 0 855 — +$6,405
Damien Alan PerrimanChief Commercial Officer 0 1 — 3,729 −$19,427

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

39/ 100

Net insider sales
1 distinct buyer5 buy · 1 sell txofficer buying

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at EXOZ

Insiders reported 5 open-market purchases of EXOZ in the trailing 90 days, across 1 distinct buyer. The most recent purchase was reported by Michael Heltzen (Chief Executive Officer) on Aug 26, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Damien Alan Perriman Chief Commercial Officer · filed Oct 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 3,729 $5.21 28,692 −12% Oct 12, 2026
Option exercise 3,922 — 32,421 +14% Oct 9, 2026
Option exercise Restricted Stock Unit 3,922 — — — Oct 9, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Edgardo Javier Rayo Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 25,000 — — — Oct 1, 2026
Christopher A. Marlett Director, 10% owner · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 10,000 — — — Oct 1, 2026
James Joseph Lalonde Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 10,000 — — — Oct 1, 2026
Anthony Digiandomenico Director, 10% owner · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 10,000 — — — Oct 1, 2026
James Ulrich Bowie Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 10,000 — — — Oct 1, 2026
Lon E. Bell Director · filed Oct 19, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 10,000 — — — Oct 1, 2026
Fouad Nawaz Vice President- Finance · filed Sep 17, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (right to buy) 45,000 — — — Sep 14, 2026
Michael Heltzen Chief Executive Officer · filed Sep 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market purchase 10b5-1 box not checked 4 $7.58 14,708 +0.0% Aug 26, 2026
Open-market purchase 10b5-1 box not checked 250 $7.60 14,453 +1.8% Aug 26, 2026
Open-market purchase 10b5-1 box not checked 251 $7.35 14,704 +1.7% Aug 26, 2026
Open-market purchase 10b5-1 box not checked 100 $7.50 13,953 +0.7% Aug 25, 2026
Open-market purchase 10b5-1 box not checked 250 $7.52 14,203 +1.8% Aug 25, 2026
Grant / award 8,841 $6.40 13,853 +176% Aug 19, 2026
Damien Alan Perriman Chief Commercial Officer · filed Aug 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Restricted Stock Unit 19,612 — — — Aug 19, 2026
Option exercise 19,612 — 28,499 +221% Aug 19, 2026
Tyler Paz Korman Chief Scientific Officer · filed Aug 25, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Restricted Stock Unit 32,964 — — — Aug 19, 2026
Option exercise 32,964 — 762,837 +4.5% Aug 19, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to EXOZ's (Oct 26, 2026).

Frequently asked about EXOZ insider activity

How many insiders bought EXOZ stock in the last 90 days?

1 distinct insider at Exozymes Inc. reported 5 open-market purchases (Form 4 code P) of EXOZ shares in the trailing 90 days, the most recent filed by Michael Heltzen (Chief Executive Officer) on Aug 26, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.

Who filed the most recent Form 4 for EXOZ?

The most recent Form 4 on this page was filed by Damien Alan Perriman (Chief Commercial Officer) on Oct 26, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market EXOZ insider sale shown?

The largest open-market sale among the filings shown was 3,729 EXOZ shares at $5.21 (about $19,427) by Damien Alan Perriman (Chief Commercial Officer) on Oct 12, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

Do the recent EXOZ insider purchases have the Form 4 10b5-1 box checked?

No. All 5 EXOZ open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Michael Heltzen (Chief Executive Officer) on Aug 26, 2026, 251 shares.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for EXOZ — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.